K

Pasithea Therapeutics Corp
D

KTTA

3.39000
USD
0.14
(4.31%)
Market Closed
Volume
0
EPS
0
Div Yield
0
P/E
-0
Market Cap
3,539,435
News

Title: Pasithea Therapeutics Corp

Sector: Healthcare
Industry: Biotechnology
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.